InvestorsHub Logo
Followers 21
Posts 2984
Boards Moderated 0
Alias Born 06/21/2014

Re: XenaLives post# 168783

Friday, 10/19/2018 11:44:35 AM

Friday, October 19, 2018 11:44:35 AM

Post# of 458250
ANAVEX gets important Rett Syndrome approval from FDA to begin!! Great news for all concerned, investors, buyers, the afflicted as well. Just put yourself in position as a parent, with great hope for a wonderful and helpful drug ahead to help their little girl - mindboggling! We can now go to CTAD and emphatically announce we are moving forward on 3-important trials for Alzheimer's, Parkinson's Dementia and Rett Syndrome, all under the banner of ANAVEX and 2-73! This is no JOKE - Big Pharma just raised their ears up!!! This announcement and further confirmatory data ahead on October 26th in Barcelona, Spain will cement us as a very serious and determined entry for many CNS Diseases! No doubt in my mind, as we pass important milestones the conversations about licensing, partnering or buyouts will get louder and louder as success comes forth! Success opens many doors and further confirms we are REAL and coming hard!!!!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News